In this comprehensive review, we aim to provide an up-to-date perspective of the intricate relationship between COPD and COVID-19. We conducted a thorough review of the literature to examine the evidence regarding the susceptibility of COPD patients to COVID-19 infection and the severity of...
Coronavirus SARS-CoV-2 is currently causing a pandemic of COVID-19, with more than 3 million confirmed cases around the globe identified as of June 2020. During these extraordinary times, caring for patients with COVID-19 and underlying COPD poses particular challenges. Certain treatments relevant...
对于慢性阻塞性肺病患者来说,担心出现Covid-19以及大流行对与其健康有关的社会基本功能和/或社会服务的影响,给他们的状况带来了额外的压力源。Covid-19大流行使慢性阻塞性肺病的常规管理和诊断更加困难,因为面对面咨询减少、进行肺量测定困难以及传统肺康复和家庭护理方案的困难。患者也面临着药物短缺的问题。(1)随...
Current and future therapies for primary Sjögren syndrome Article 29 June 2021 Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease Article 08 July 2020 The immunology of long COVID Article 11 July 2023 References Barnes, P. J. Chronic obstructive pulmonary di...
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care. January 31st 2025 Medicare Advantage Enrollees Use Less End-of-Life Home Health Care, Study F...
During the 52-week treatment period, patients in NOTUS and BOREAS received Dupixent or placebo every two weeks added to a maximal standard-of-care inhaled triple therapy of inhaled corticosteroids (ICS), long-acting beta agonists (LABA), and long-acting muscarinic antagonists (LAMA). Double main...
COVID-19患者中合并哮喘、慢性阻塞性肺疾病(COPD)和哮喘慢阻肺重叠(ACO)的患病率不同,死亡风险也不同。本文推介研究旨在通过系统综述和荟萃分析,评估哮喘、COPD和ACO作为合并症的患病率,并确定其在COVID-19患者中的死亡风险。 关键词:COVID-19;哮喘;慢性阻塞性肺疾病;哮喘合并慢阻肺 ...
The link between the heart and the lungs Benefits of portable spirometry in long-COVID & COPD Back to the basics: The lungs COPD Awareness Month Importance of respiratory therapists, now, more than ever Managing lung disease in the heat of summer Why lung health matters The truth about COPD...
A recent criticism of GOLD 2023 is the lack of focus on COPD in low-income or resource-poor settings [25]. More information is required regarding long-COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), in patients with COPD and the long-term effects of severe COVID-19 in...
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE